ARCHIVES

With $10.4 Billion To Spend In 18 Months, NIH Says Money Will Be Spent Rationally. Funds Will Support R01s

This article is from The Cancer Letter archive.

Vol. 35 No. 07 | February 20, 2009

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

NCAB Asks Speedup Of OSP Coordinating Center Review

October 14, 1983

Shorter, Simpler Consent Form Proposed For Phase I Trials

July 31, 2009

M.D. Anderson Wins 11th SPORE Grant.

July 3, 2008

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010